Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Microsaic Systems Appoints Colin Jump as New CEO

Published: Tuesday, November 06, 2012
Last Updated: Tuesday, November 06, 2012
Bookmark and Share
Company to drive the commercialization of its revolutionary chip-based technology.

With over 30 years of experience working in the analytical instrumentation sector, Colin has a proven track record helping companies to achieve significant growth and will bring a vast amount of commercial and operational acumen to the role.

Prior to joining Microsaic, Colin was responsible for developing and growing Shimadzu UK Ltd, a global manufacturer of scientific research instruments.

As UK Managing Director of Shimadzu UK Ltd for the past 11 years, Colin led the company using his extensive business experience and industry knowledge to implement comprehensive growth and marketing communication strategies, both of which will be invaluable in the development and growth of Microsaic Systems going forward.

Before managing Shimadzu UK Ltd, Colin was European Commercial Director at SGE Europe Ltd, which followed seven years in senior management and marketing positions at Mallinckrodt Baker in the UK and the Netherlands.

In addition, his prior roles in sales and marketing positions at Bayer Diagnostics, Boehringer Mannheim UK and Wellcome Diagnostics will undoubtedly be beneficial to Mircosaic Systems as it looks to establish its innovative chip-based scientific instruments within the analytical instrumentation market.

“Microsaic Systems is the first and only company to have commercialized MS (mass spectrometry) technology on a chip,” said Colin Jump.

“This places the company in an optimal position to deliver this gold standard technique for chemical analysis to a much wider range of users and applications.”

He continues, “I am excited to be joining Microsaic Systems at this crucial stage as it accelerates the commercialization of its revolutionary chip-based technology. With the ability to address major opportunities across multiple market areas I see huge potential for the technology and for the Company in the years ahead.”

“Our breakthrough product, the 3500 MiD, represents a step change in the ease of use and footprint of mass spectrometry. The instrument is smaller, lighter, consumes less energy, is easier to maintain and cheaper to run than conventional MS systems,” comments Eric Yeatman, Acting CEO of Microsaic Systems.

Yeatman continued, “The Board is very pleased to welcome Colin Jump to the company as our new CEO and I have no doubt his commercial and operational experience in the analytical instrumentation sector will help drive the business forward towards the further realization of our corporate goals.”

The 3500 MiD is the culmination of over a decade of research, bringing together two high tech fields - chemical analysis and silicon micro-engineering - to make possible a transformative capability in detection.

Its low operating cost and small footprint make the 3500 MiD deployable in a wide range of applications where mass spectrometry has not been able to reach - until now.

Colin Jump will take up his role on 5th November 2012, at which point Eric Yeatman and Colin Nicholl will resume their former roles as Chairman and Deputy Chairman, respectively.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Microsaic Systems Signs Commercial Agreement
Second major agreement for novel miniaturized chip-based scientific instrument.
Thursday, April 11, 2013
Microsaic Systems Wins R&D 100 Award for the World’s Most Compact Mass Spectrometer
Microsaic’s 3500 MiD mass spectrometer has been chosen winner by an independent judging panel and the editors of R&D Magazine.
Friday, June 22, 2012
Microsaic Systems Appoint Sales and Marketing Manager
Microsaic Systems plc announces that Samantha Dunnage has joined to lead the Company’s marketing and direct sales.
Monday, August 08, 2011
Microsaic Systems - First-to-market Developer of Miniaturized Chip-based Scientific Instruments
Microsaic Systems plc, has announced that it has raised gross proceeds of £4 million by way of an institutional placing in connection with the forthcoming admission of its shares to trading on the AIM market of the London Stock Exchange.
Wednesday, April 06, 2011
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
A Peachy Defense System for Seeds
ETH chemists are developing a new coating method to protect seeds from being eaten by insects. In doing so, they have drawn inspiration from the humble peach and a few of its peers.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!